Influence of common and rare genetic variation on warfarin dose among African–Americans and European–Americans using the exome array

Perilipin 5 is protective in the ischemic heart

(2016) Christina Drevinge et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

(2016) Niclas Eriksson et al.   PHARMACOGENOMICS

Race-Specific Influence ofCYP4F2on Dose and Risk of Hemorrhage Among Warfarin Users

(2016) Aditi Shendre et al.   PHARMACOTHERAPY

Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk

(2016) Jonathan C. Hsu et al.   JAMA Cardiology

Race influences warfarin dose changes associated with genetic factors

(2015) N. A. Limdi et al.   BLOOD

Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR

(2015) Hui Yang et al.   Nature Protocols

Perilipin 5, a lipid droplet protein adapted to mitochondrial energy utilization

(2014) Alan R. Kimmel et al.   CURRENT OPINION IN LIPIDOLOGY

National Utilization Patterns of Warfarin Use in Older Patients with Atrial Fibrillation: A Population-Based Study of Medicare Part D Beneficiaries

(2013) Mukaila A Raji et al.   ANNALS OF PHARMACOTHERAPY

Genome-wide analysis of parent-of-origin effects in non-syndromic orofacial clefts

(2013) Paras Garg et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Genome-wide Association Studies of Pit-and-Fissure- and Smooth-surface Caries in Permanent Dentition

(2013) Z. Zeng et al.   JOURNAL OF DENTAL RESEARCH

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

(2013) Minoli A Perera et al.   LANCET

Controlling population structure in human genetic association studies with samples of unrelated individuals

(2013) David B. Allison et al.   Statistics and Its Interface

Practical consideration of genotype imputation: Sample size, window size, reference choice, and untyped rate

(2013) Guimin Gao et al.   Statistics and Its Interface

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011

(2012) Kate Kirley et al.  

Perilipin 5, a Lipid Droplet-binding Protein, Protects Heart from Oxidative Burden by Sequestering Fatty Acid from Excessive Oxidation

(2012) Kenta Kuramoto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Practice-Level Variation in Warfarin Use Among Outpatients With Atrial Fibrillation (from the NCDR PINNACLE Program)

(2011) Paul S. Chan et al.   AMERICAN JOURNAL OF CARDIOLOGY

Emergency Hospitalizations for Adverse Drug Events in Older Americans

(2011) Daniel S. Budnitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Performance of Genotype Imputation for Rare Variants Identified in Exons and Flanking Regions of Genes

(2011) Li Li et al.   PLoS One

Molecular defects of the platelet P2 receptors

(2011) Marco Cattaneo   Purinergic Signalling

National Estimates of Emergency Department Visits for Hemorrhage-Related Adverse Events From Clopidogrel Plus Aspirin and From Warfarin

(2010) Nadine Shehab et al.   ARCHIVES OF INTERNAL MEDICINE

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

(2010) N. A. Limdi et al.   BLOOD

Evaluation of Pharmacogenetic Algorithm for Warfarin Dose Requirements in Japanese Patients

(2010) Fumihiko Takeuchi et al.   CIRCULATION JOURNAL

Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans

(2010) L H Cavallari et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese

(2010) P.-C. Cha et al.   HUMAN MOLECULAR GENETICS

Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans

(2010) Chen Liu et al.   JOURNAL OF HYPERTENSION

Genotype imputation for genome-wide association studies

(2010) Jonathan Marchini et al.   NATURE REVIEWS GENETICS

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

(2010) K. Wang et al.   NUCLEIC ACIDS RESEARCH

Analyses and Comparison of Imputation-Based Association Methods

(2010) Yu-Fang Pei et al.   PLoS One

Genotype Imputation

(2009) Yun Li et al.   Annual Review of Genomics and Human Genetics

An evaluation of statistical approaches to rare variant analysis in genetic association studies

(2009) Andrew P. Morris et al.   GENETIC EPIDEMIOLOGY

A genome-wide association study of acenocoumarol maintenance dosage

(2009) Martina Teichert et al.   HUMAN MOLECULAR GENETICS

Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate

(2009) Elisabeth Mangold et al.   NATURE GENETICS

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

(2009) Fumihiko Takeuchi et al.   PLoS Genetics

CYP4F2 genetic variant alters required warfarin dose

(2008) M. D. Caldwell et al.   BLOOD

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

(2008) G. M. Cooper et al.   BLOOD

FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities

(2008) S Allerstorfer et al.   ONCOGENE

VKORC1polymorphisms, haplotypes and haplotype groups on warfarin dose among African–Americans and European–Americans

(2008) Nita A Limdi et al.   PHARMACOGENOMICS

Analyses and Comparison of Accuracy of Different Genotype Imputation Methods

(2008) Yu-Fang Pei et al.   PLoS One